Krabeva 100mg Injection

generic_icon
Report Error

Composition FOR Krabeva 100mg Injection

Bevacizumab(100mg)

food interaction for Krabeva Injection

alcohol interaction for Krabeva Injection

pregnancy interaction for Krabeva Injection

lactation interaction for Krabeva Injection

food
alcohol
pregnancy
lactation
No interaction found/established
It is not known whether it is safe to consume alcohol with Krabeva 100mg Injection. Please consult your doctor.
CONSULT YOUR DOCTOR
Krabeva 100mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
CONSULT YOUR DOCTOR
Krabeva 100mg Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
CONSULT YOUR DOCTOR

SALT INFORMATION FOR Krabeva 100mg Injection

Bevacizumab(100mg)

Krabeva injection uses

How krabeva injection works

Krabeva 100mg Injection is a anti-angiogenic medication. It works by blocking a protein called vascular endothelial growth factor (VEGF). This stops the formation of blood vessels that bring oxygen and nutrients to cancerous cells.

Common side effects of krabeva injection

Nosebleeds, Headache, High blood pressure, Inflammation of the nose, Protein in urine, Taste change, Dry skin, Hemorrhage, Increased lacrimation, Back pain, Exfoliative dermatitis

SUBSTITUTES FOR Krabeva Injection

16 Substitutes
16 Substitutes
Sorted By
RelevancePrice

Expert advice FOR Krabeva Injection

  • Bevacizumab is an effective, first-line option when used together with other medicines for certain types of cancers such as colorectal, lung, cervical, and kidney cancers.
  • Bevacizumab is given as an infusion. Your doctor or nurse will monitor you for signs of an infusion reaction such as high blood pressure and trouble breathing.
  • It can lower your wound healing ability. Inform your doctor that you are taking this medication before undergoing any surgical procedure.
  • It can increase the risk of bleeding. Inform your doctor if you notice any unusual bleeding or bleeding that doesn't stop easily.
  • Your doctor may regularly check your blood pressure and levels of protein in your urine while you are on Bevacizumab.

Frequently asked questions FOR Krabeva 100mg Injection

Bevacizumab

Q. What kinds of cancer can Krabeva 100mg Injection be used for ?
Krabeva 100mg Injection is approved for the treatment of cancer of the colon or rectum that has spread to other parts of the body. It must be given along with chemotherapy. Other types of cancers that it helps with includes certain types of lung cancer, kidney cancer, ovarian cancer, cervical cancer, and glioblastoma (a type of brain tumor).
Q. How is Krabeva 100mg Injection given?
Krabeva 100mg Injection is given as an infusion. That means you get it through a small needle in your vein or through a port, which is a device placed under your skin. Your doctor will decide your dose and duration and will monitor you for signs of an infusion reaction.
Q. How long can I take Krabeva 100mg Injection for?
You keep taking Krabeva 100mg Injection as long as your disease is controlled and your side effects are manageable. Your doctor will determine whether you should stop taking Krabeva 100mg Injection. If your cancer progresses during this initial treatment, talk to your doctor if a different chemotherapy may be an option.
Show More
Q. How Krabeva 100mg Injection works differently from chemotherapy?
Chemotherapy attacks fast-growing cells, like cancer cells. In contrast, the purpose of Krabeva 100mg Injection is to prevent the growth of new blood vessels that feed tumors. This causes the tumour to shrink, or to stop growing.
Q. Does a person taking Krabeva 100mg Injection still need chemotherapy?
Chemotherapy is still needed along with taking Krabeva 100mg Injection. It makes chemotherapy work better.

Content on this page was last updated on 10 February, 2025, by Dr. Rajeev Sharma (MBA, MBBS)